GSK says Witty will retire in March 2017

17 March 2016 - Deborah Wilkes


GlaxoSmithKline has announced that Sir Andrew Witty will retire as chief executive officer on 31 March 2017, after more than three decades at the UK-based pharmaceutical company.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: